Quarterly report pursuant to Section 13 or 15(d)

Note Payable - PPP Loan

Note Payable - PPP Loan
3 Months Ended
Sep. 30, 2022
Debt Disclosure [Abstract]  
Note Payable - PPP Loan

13.   Note Payable – PPP Loan

On April 16, 2020, the Company received $600,000 related to its filing under the Paycheck Protection Program and Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"). The Company elected to treat the SBA Loans as debt under ASC 470, “Debt”.

On July 21, 2021, iBio was granted forgiveness in repaying the loan.  In accordance with ASC 405-20-40, “Liabilities - Extinguishments of Liabilities – Derecognition”, the Company derecognized the liability and accrued interest of approximately $7,000 in the first quarter of Fiscal 2022.  The forgiveness is included in loss from discontinued operations (see Note 3 – Discontinued Operations).